Lawyers

• 

  Judge In Luigi Mangione Case Married To Ex-Pfizer Executive, Owns Thousands In Healthcare Stock: Report

  The judge presiding over pre-trial hearings for Luigi Mangione has come under scrutiny for her financial and familial ties to the healthcare industry.

• New US inversion rules threaten Pfizer-Allergan merge deal

  The deal between Pfizer and Allergan, two of the prominent drugmakers, is threatened by the new US inversion rules done by the US Treasury Department.

• US Treasury Department imposes new rules to prevent 'earnings stripping' practices

  A new set of rules will be imposed by the U.S Treasury Department to prevent U.S companies from practicing earning stripping. U.S companies often engage on these practices to prevent the high taxation rate of the United States.

• Pfizer unit to pay $784.6 million in Medicaid refund settlement

  Pfizer's Wyeth unit has already agreed to pay $784.6 million. This will allegedly settle claims that the company's calculation of the Medicaid rebates for Protonix violated the Federal Civil False Claims Act and other laws.

• Corruption tars drug industry drive to improve access for poor

  The world's top drugmakers have improved access to medicines in developing countries, according to a report on Monday, but their good work is undermined by a sorry record of unethical behavior.

• Pfizer executives: new Treasury rules hamstring inversion deals

  Pfizer Inc's finance chief said on Tuesday that new rules by the U.S. Treasury will make it "prohibitively harder" for American companies to buy foreign firms in order to relocate to lower-tax jurisdictions.

• Teva Pharma Reaches Settlement with Pfizer over Celebrex Patent

  In a statement, Pfizer confirms a settlement agreement with Teva as to the manufacture of a generic version of Celebrex but maintains the validity of its existing patent over the drug.